Literature DB >> 15851477

Essential role of p38gamma in K-Ras transformation independent of phosphorylation.

Jun Tang1, Xiaomei Qi, Dan Mercola, Jiahuai Han, Guan Chen.   

Abstract

MAPK cascades play the critical role in regulating Ras oncogene activity by phosphorylation-dependent mechanisms. Whereas the ERK MAPK pathway is required for Ras transformation, our previous works established that the p38 activity is inhibitory to Ras signaling in both experimental and ras-mutated cancer cells (Chen, G., Hitomi, M., Han, J., and Stacey, D. W. (2000) J. Biol. Chem. 275, 38973-38980; Qi, X., Tang, J., Pramanik, R., Schultz, R. M., Shirasawa, S., Sasazuki, T., Han, J., and Chen, G. (2004) J. Biol. Chem., 279, 22138-22144). Here we report that K-Ras activated p38gamma, a p38 MAPK family member, by inducing its expression without increasing its phosphorylation and that depletion of induced p38gamma suppressed Ras transformation in rat intestinal epithelial cells. This p38gamma activity contrasts with that of its family member, p38alpha, which is activated by Ras through phosphorylation, leading to an inhibition of Ras transformation. Mechanistic analyses showed that unphosphorylated p38gamma may promote Ras transformation through an increased complex formation with ERK proteins. Significantly, functional p38gamma protein was expressed only in K-ras-mutated human colon cancer cells, and p38gamma transcripts were ubiquitously increased in a set of primary human colon cancer tissues. These studies thus demonstrate the essential role of p38gamma in K-Ras transformation independent of phosphorylation, and elevated p38gamma may serve as a novel diagnostic marker and therapeutic target for human colon cancer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15851477      PMCID: PMC1224721          DOI: 10.1074/jbc.M500699200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  59 in total

Review 1.  Elucidating cell signaling mechanisms using antisense technology.

Authors:  E Koller; W A Gaarde; B P Monia
Journal:  Trends Pharmacol Sci       Date:  2000-04       Impact factor: 14.819

Review 2.  p38 MAP kinases: beyond the stress response.

Authors:  A R Nebreda; A Porras
Journal:  Trends Biochem Sci       Date:  2000-06       Impact factor: 13.807

Review 3.  The p38 signal transduction pathway: activation and function.

Authors:  K Ono; J Han
Journal:  Cell Signal       Date:  2000-01       Impact factor: 4.315

4.  Cisplatin and UV radiation induce activation of the stress-activated protein kinase p38gamma in human melanoma cells.

Authors:  M J Pillaire; A R Nebreda; J M Darbon
Journal:  Biochem Biophys Res Commun       Date:  2000-11-30       Impact factor: 3.575

5.  Ras stimulates DNA topoisomerase II alpha through MEK: a link between oncogenic signaling and a therapeutic target.

Authors:  G Chen; D Templeton; D P Suttle; D W Stacey
Journal:  Oncogene       Date:  1999-11-25       Impact factor: 9.867

6.  Opposing role of mitogen-activated protein kinase subtypes, erk-1/2 and p38, in the regulation of chondrogenesis of mesenchymes.

Authors:  C D Oh; S H Chang; Y M Yoon; S J Lee; Y S Lee; S S Kang; J S Chun
Journal:  J Biol Chem       Date:  2000-02-25       Impact factor: 5.157

7.  Selective activation of p38alpha and p38gamma by hypoxia. Role in regulation of cyclin D1 by hypoxia in PC12 cells.

Authors:  P W Conrad; R T Rust; J Han; D E Millhorn; D Beitner-Johnson
Journal:  J Biol Chem       Date:  1999-08-13       Impact factor: 5.157

8.  The p38 pathway provides negative feedback for Ras proliferative signaling.

Authors:  G Chen; M Hitomi; J Han; D W Stacey
Journal:  J Biol Chem       Date:  2000-12-15       Impact factor: 5.157

9.  TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins.

Authors:  F Kanai; P A Marignani; D Sarbassova; R Yagi; R A Hall; M Donowitz; A Hisaminato; T Fujiwara; Y Ito; L C Cantley; M B Yaffe
Journal:  EMBO J       Date:  2000-12-15       Impact factor: 11.598

10.  Involvement of the MKK6-p38gamma cascade in gamma-radiation-induced cell cycle arrest.

Authors:  X Wang; C H McGowan; M Zhao; L He; J S Downey; C Fearns; Y Wang; S Huang; J Han
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

View more
  32 in total

1.  p38gamma regulates interaction of nuclear PSF and RNA with the tumour-suppressor hDlg in response to osmotic shock.

Authors:  Guadalupe Sabio; María I Cerezo-Guisado; Paloma Del Reino; Francisco A Iñesta-Vaquera; Simon Rousseau; J Simon C Arthur; David G Campbell; Francisco Centeno; Ana Cuenda
Journal:  J Cell Sci       Date:  2010-07-06       Impact factor: 5.285

2.  MAPKs' status at early stages of renal carcinogenesis and tumors induced by ferric nitrilotriacetate.

Authors:  Francisco A Aguilar-Alonso; José D Solano; Chabetty Y Vargas-Olvera; Ignacio Pacheco-Bernal; Telma O Pariente-Pérez; María Elena Ibarra-Rubio
Journal:  Mol Cell Biochem       Date:  2015-02-28       Impact factor: 3.396

3.  PTPH1 dephosphorylates and cooperates with p38gamma MAPK to increase ras oncogenesis through PDZ-mediated interaction.

Authors:  Song-Wang Hou; Hui-Ying Zhi; Nicole Pohl; Mathew Loesch; Xiao-Mei Qi; Rong-Shan Li; Zainab Basir; Guan Chen
Journal:  Cancer Res       Date:  2010-03-23       Impact factor: 12.701

4.  p38γ promotes breast cancer cell motility and metastasis through regulation of RhoC GTPase, cytoskeletal architecture, and a novel leading edge behavior.

Authors:  Devin T Rosenthal; Harish Iyer; Silvia Escudero; Liwei Bao; Zhifen Wu; Alejandra C Ventura; Celina G Kleer; Ellen M Arruda; Krishna Garikipati; Sofia D Merajver
Journal:  Cancer Res       Date:  2011-08-23       Impact factor: 12.701

5.  The K-Ras effector p38γ MAPK confers intrinsic resistance to tyrosine kinase inhibitors by stimulating EGFR transcription and EGFR dephosphorylation.

Authors:  Ning Yin; Adrienne Lepp; Yongsheng Ji; Matthew Mortensen; Songwang Hou; Xiao-Mei Qi; Charles R Myers; Guan Chen
Journal:  J Biol Chem       Date:  2017-07-24       Impact factor: 5.157

6.  p38γ Mitogen-activated protein kinase signals through phosphorylating its phosphatase PTPH1 in regulating ras protein oncogenesis and stress response.

Authors:  Songwang Hou; Padmanaban S Suresh; Xiaomei Qi; Adrienne Lepp; Shama P Mirza; Guan Chen
Journal:  J Biol Chem       Date:  2012-06-22       Impact factor: 5.157

7.  p38γ mitogen-activated protein kinase (MAPK) confers breast cancer hormone sensitivity by switching estrogen receptor (ER) signaling from classical to nonclassical pathway via stimulating ER phosphorylation and c-Jun transcription.

Authors:  Xiaomei Qi; Huiying Zhi; Adrienne Lepp; Phillip Wang; Jian Huang; Zainab Basir; Christopher R Chitambar; Charles R Myers; Guan Chen
Journal:  J Biol Chem       Date:  2012-03-07       Impact factor: 5.157

8.  p38gamma mitogen-activated protein kinase integrates signaling crosstalk between Ras and estrogen receptor to increase breast cancer invasion.

Authors:  Xiaomei Qi; Jun Tang; Mathew Loesch; Nicole Pohl; Serhan Alkan; Guan Chen
Journal:  Cancer Res       Date:  2006-08-01       Impact factor: 12.701

9.  p38gamma MAPK cooperates with c-Jun in trans-activating matrix metalloproteinase 9.

Authors:  Mathew Loesch; Hui-Ying Zhi; Song-Wang Hou; Xiao-Mei Qi; Rong-Shan Li; Zainab Basir; Thomas Iftner; Ana Cuenda; Guan Chen
Journal:  J Biol Chem       Date:  2010-03-15       Impact factor: 5.157

10.  p38γ MAPK is required for inflammation-associated colon tumorigenesis.

Authors:  N Yin; X Qi; S Tsai; Y Lu; Z Basir; K Oshima; J P Thomas; C R Myers; G Stoner; G Chen
Journal:  Oncogene       Date:  2015-05-11       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.